Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis

被引：41
作者：
Oliver S.L. [1 ]
Yang E. [1 ]
Arvin A.M. [1 ,2 ]
机构：
[1] Department of Pediatrics, Stanford University School of Medicine, Stanford, 94305-5208, CA
[2] Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, 94305-5208, CA
来源：
Current Clinical Microbiology Reports | 2016年 / 3卷 / 4期
关键词：
Fusion; Glycoprotein; Pathogenesis; Receptor; Replication; Varicella-zoster virus;
D O I：
10.1007/s40588-016-0044-4
中图分类号：
学科分类号：
摘要：
Purpose of Review: Varicella-zoster virus (VZV), an alphaherpesvirus that causes chicken pox (varicella) and shingles (herpes zoster), is a medically important pathogen that causes considerable morbidity and, on occasion, mortality in immunocompromised patients. Herpes zoster can afflict the elderly with a debilitating condition, postherpetic neuralgia, triggering severe, untreatable pain for months or years. The lipid envelope of VZV, similar to all herpesviruses, contains numerous glycoproteins required for replication and pathogenesis. This study aims to summarize the current knowledge about VZV glycoproteins and their roles in cell entry, replication, and pathogenesis. Recent Findings: The functions for some VZV glycoproteins are known, such as gB, gH, and gL, in membrane fusion, cell-cell fusion regulation, and receptor binding properties. However, the molecular mechanisms that trigger or mediate VZV glycoproteins remain poorly understood. Summary: VZV glycoproteins are central to successful replication but their modus operandi during replication and pathogenesis remains elusive requiring further mechanistic-based studies. © 2016, Springer International Publishing AG.
引用
收藏
页码：204 / 215
页数：11
相关论文
共 100 条
[61]  
Johnson D.C., Ligas M.W., Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors, J Virol, 62, pp. 4605-4612, (1988)
[62]  
Karger A., Mettenleiter T.C., Glycoproteins gIII and gp50 play dominant roles in the biphasic attachment of pseudorabies virus, Virology, 194, pp. 654-664, (1993)
[63]  
Mettenleiter T.C., Zsak L., Zuckermann F., Sugg N., Kern H., Ben-Porat T., Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus, J Virol, 64, pp. 278-286, (1990)
[64]  
Laquerre S., Argnani R., Anderson D.B., Zucchini S., Manservigi R., Glorioso J.C., Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread, J Virol, 72, pp. 6119-6130, (1998)
[65]  
Cohen J.I., Seidel K.E., Absence of varicella-zoster virus (VZV) glycoprotein V does not alter growth of VZV in vitro or sensitivity to heparin, J Gen Virol, 75, pp. 3087-3093, (1994)
[66]  
Gray W.L., Byrne B.H., Characterization of the simian varicella virus glycoprotein C, which is nonessential for in vitro replication, Arch Virol, 148, pp. 537-545, (2003)
[67]  
Storlie J., Carpenter J.E., Jackson W., Grose C., Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles, Virology, 382, pp. 171-181, (2008)
[68]  
Storlie J., Jackson W., Hutchinson J., Grose C., Delayed biosynthesis of varicella-zoster virus glycoprotein C: upregulation by hexamethylene bisacetamide and retinoic acid treatment of infected cells, J Virol, 80, pp. 9544-9556, (2006)
[69]  
Adamiak B., Trybala E., Mardberg K., Johansson M., Liljeqvist J.A., Olofsson S., Et al., Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain, Virology, 400, pp. 197-206, (2010)
[70]  
Li Q., Ali M.A., Cohen J.I., Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread, Cell, 127, pp. 305-316, (2006)
12345678910